Use of nanoparticles to increase the systemic bioavailability of trans-resveratrol

Resveratrol is a substance of plant origin with antioxidant, anti-inflammatory, and chemoprotective properties used as a biologically active supplement in the prophylaxis of myocardial infarction, types 1 and 2 diabetes, and tumors. The aim of the present work was to develop and perform pharmacokine...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmaceutical chemistry journal 2010-06, Vol.44 (2), p.74-76
Hauptverfasser: Oganesyan, E. A, Miroshnichenko, I. I, Vikhrieva, N. S, Lyashenko, A. A, Leshkov, S. Yu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 76
container_issue 2
container_start_page 74
container_title Pharmaceutical chemistry journal
container_volume 44
creator Oganesyan, E. A
Miroshnichenko, I. I
Vikhrieva, N. S
Lyashenko, A. A
Leshkov, S. Yu
description Resveratrol is a substance of plant origin with antioxidant, anti-inflammatory, and chemoprotective properties used as a biologically active supplement in the prophylaxis of myocardial infarction, types 1 and 2 diabetes, and tumors. The aim of the present work was to develop and perform pharmacokinetic studies of a nanosomal form of resveratrol. The techniques described here yield particles of submicron size, with resveratrol yields of 70-100% and resveratrol contents in lyophilized formulations reaching 15-20%. After oral administration of unmodified resveratrol to mice, only 19% of the dose was taken up into the blood, while use of nanosomal resveratrol formulations based on Eudragit RL and lecithin/chitosan increased bioavailability to 39% and 61% respectively. Increases in the peak plasma resveratrol concentration by factors of 4-5 were also seen in mice given nanoparticles. Thus, conversion of resveratrol to the nanosomal form leads to solubilization and resultant increases in absorption into the bloodstream.
doi_str_mv 10.1007/s11094-010-0401-1
format Article
fullrecord <record><control><sourceid>gale_cross</sourceid><recordid>TN_cdi_gale_infotracmisc_A359334795</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A359334795</galeid><sourcerecordid>A359334795</sourcerecordid><originalsourceid>FETCH-LOGICAL-c379t-b629717e2d631a7fb59968f8c05b4447dfd1f24f6bbfec4d768cd3969b97e5243</originalsourceid><addsrcrecordid>eNp9kE9LAzEQxYMoWKsfwJMLnrfObLKb5liK_6AgqAVvIZtNasp2U5K10G9vlvUiiMxhYOb9hnmPkGuEGQLwu4gIguWAkAMDzPGETLDkNBdA8ZRMAEQalvBxTi5i3EISAi0m5HUdTeZt1qnO71XonW5NzHqfuU4Ho9Ky_zRZPMbe7JzOaufVQblW1a51_XEg-6C6mAcTDyaoPvj2kpxZ1UZz9dOnZP1w_758ylcvj8_LxSrXlIs-r6tCcOSmaCqKitu6FKKa27mGsmaM8cY2aAtmq7q2RrOGV3PdUFGJWnBTFoxOye14d6NaI11nfXpF71zUckFLQSnjokyq2R-qVM1gyHfGujT_BeAI6OBjDMbKfXA7FY4SQQ5ZyzFrmSKUQ9YSE1OMTEzabmOC3Pqv0CX3_0I3I2SVl2oTXJTrtwKQAs45VJTRb26xioQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Use of nanoparticles to increase the systemic bioavailability of trans-resveratrol</title><source>SpringerNature Journals</source><creator>Oganesyan, E. A ; Miroshnichenko, I. I ; Vikhrieva, N. S ; Lyashenko, A. A ; Leshkov, S. Yu</creator><creatorcontrib>Oganesyan, E. A ; Miroshnichenko, I. I ; Vikhrieva, N. S ; Lyashenko, A. A ; Leshkov, S. Yu</creatorcontrib><description>Resveratrol is a substance of plant origin with antioxidant, anti-inflammatory, and chemoprotective properties used as a biologically active supplement in the prophylaxis of myocardial infarction, types 1 and 2 diabetes, and tumors. The aim of the present work was to develop and perform pharmacokinetic studies of a nanosomal form of resveratrol. The techniques described here yield particles of submicron size, with resveratrol yields of 70-100% and resveratrol contents in lyophilized formulations reaching 15-20%. After oral administration of unmodified resveratrol to mice, only 19% of the dose was taken up into the blood, while use of nanosomal resveratrol formulations based on Eudragit RL and lecithin/chitosan increased bioavailability to 39% and 61% respectively. Increases in the peak plasma resveratrol concentration by factors of 4-5 were also seen in mice given nanoparticles. Thus, conversion of resveratrol to the nanosomal form leads to solubilization and resultant increases in absorption into the bloodstream.</description><identifier>ISSN: 0091-150X</identifier><identifier>EISSN: 1573-9031</identifier><identifier>DOI: 10.1007/s11094-010-0401-1</identifier><language>eng</language><publisher>Boston: Boston : Springer US</publisher><subject>Antioxidants ; bioavailability ; Heart attack ; Medicine ; Nanoparticles ; Organic Chemistry ; pharmacokinetics ; Pharmacology/Toxicology ; Pharmacy ; Resveratrol</subject><ispartof>Pharmaceutical chemistry journal, 2010-06, Vol.44 (2), p.74-76</ispartof><rights>Springer Science+Business Media, Inc. 2010</rights><rights>COPYRIGHT 2010 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c379t-b629717e2d631a7fb59968f8c05b4447dfd1f24f6bbfec4d768cd3969b97e5243</citedby><cites>FETCH-LOGICAL-c379t-b629717e2d631a7fb59968f8c05b4447dfd1f24f6bbfec4d768cd3969b97e5243</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11094-010-0401-1$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11094-010-0401-1$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids></links><search><creatorcontrib>Oganesyan, E. A</creatorcontrib><creatorcontrib>Miroshnichenko, I. I</creatorcontrib><creatorcontrib>Vikhrieva, N. S</creatorcontrib><creatorcontrib>Lyashenko, A. A</creatorcontrib><creatorcontrib>Leshkov, S. Yu</creatorcontrib><title>Use of nanoparticles to increase the systemic bioavailability of trans-resveratrol</title><title>Pharmaceutical chemistry journal</title><addtitle>Pharm Chem J</addtitle><description>Resveratrol is a substance of plant origin with antioxidant, anti-inflammatory, and chemoprotective properties used as a biologically active supplement in the prophylaxis of myocardial infarction, types 1 and 2 diabetes, and tumors. The aim of the present work was to develop and perform pharmacokinetic studies of a nanosomal form of resveratrol. The techniques described here yield particles of submicron size, with resveratrol yields of 70-100% and resveratrol contents in lyophilized formulations reaching 15-20%. After oral administration of unmodified resveratrol to mice, only 19% of the dose was taken up into the blood, while use of nanosomal resveratrol formulations based on Eudragit RL and lecithin/chitosan increased bioavailability to 39% and 61% respectively. Increases in the peak plasma resveratrol concentration by factors of 4-5 were also seen in mice given nanoparticles. Thus, conversion of resveratrol to the nanosomal form leads to solubilization and resultant increases in absorption into the bloodstream.</description><subject>Antioxidants</subject><subject>bioavailability</subject><subject>Heart attack</subject><subject>Medicine</subject><subject>Nanoparticles</subject><subject>Organic Chemistry</subject><subject>pharmacokinetics</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacy</subject><subject>Resveratrol</subject><issn>0091-150X</issn><issn>1573-9031</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNp9kE9LAzEQxYMoWKsfwJMLnrfObLKb5liK_6AgqAVvIZtNasp2U5K10G9vlvUiiMxhYOb9hnmPkGuEGQLwu4gIguWAkAMDzPGETLDkNBdA8ZRMAEQalvBxTi5i3EISAi0m5HUdTeZt1qnO71XonW5NzHqfuU4Ho9Ky_zRZPMbe7JzOaufVQblW1a51_XEg-6C6mAcTDyaoPvj2kpxZ1UZz9dOnZP1w_758ylcvj8_LxSrXlIs-r6tCcOSmaCqKitu6FKKa27mGsmaM8cY2aAtmq7q2RrOGV3PdUFGJWnBTFoxOye14d6NaI11nfXpF71zUckFLQSnjokyq2R-qVM1gyHfGujT_BeAI6OBjDMbKfXA7FY4SQQ5ZyzFrmSKUQ9YSE1OMTEzabmOC3Pqv0CX3_0I3I2SVl2oTXJTrtwKQAs45VJTRb26xioQ</recordid><startdate>20100601</startdate><enddate>20100601</enddate><creator>Oganesyan, E. A</creator><creator>Miroshnichenko, I. I</creator><creator>Vikhrieva, N. S</creator><creator>Lyashenko, A. A</creator><creator>Leshkov, S. Yu</creator><general>Boston : Springer US</general><general>Springer US</general><general>Springer</general><scope>FBQ</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20100601</creationdate><title>Use of nanoparticles to increase the systemic bioavailability of trans-resveratrol</title><author>Oganesyan, E. A ; Miroshnichenko, I. I ; Vikhrieva, N. S ; Lyashenko, A. A ; Leshkov, S. Yu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c379t-b629717e2d631a7fb59968f8c05b4447dfd1f24f6bbfec4d768cd3969b97e5243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Antioxidants</topic><topic>bioavailability</topic><topic>Heart attack</topic><topic>Medicine</topic><topic>Nanoparticles</topic><topic>Organic Chemistry</topic><topic>pharmacokinetics</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacy</topic><topic>Resveratrol</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Oganesyan, E. A</creatorcontrib><creatorcontrib>Miroshnichenko, I. I</creatorcontrib><creatorcontrib>Vikhrieva, N. S</creatorcontrib><creatorcontrib>Lyashenko, A. A</creatorcontrib><creatorcontrib>Leshkov, S. Yu</creatorcontrib><collection>AGRIS</collection><collection>CrossRef</collection><jtitle>Pharmaceutical chemistry journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Oganesyan, E. A</au><au>Miroshnichenko, I. I</au><au>Vikhrieva, N. S</au><au>Lyashenko, A. A</au><au>Leshkov, S. Yu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Use of nanoparticles to increase the systemic bioavailability of trans-resveratrol</atitle><jtitle>Pharmaceutical chemistry journal</jtitle><stitle>Pharm Chem J</stitle><date>2010-06-01</date><risdate>2010</risdate><volume>44</volume><issue>2</issue><spage>74</spage><epage>76</epage><pages>74-76</pages><issn>0091-150X</issn><eissn>1573-9031</eissn><abstract>Resveratrol is a substance of plant origin with antioxidant, anti-inflammatory, and chemoprotective properties used as a biologically active supplement in the prophylaxis of myocardial infarction, types 1 and 2 diabetes, and tumors. The aim of the present work was to develop and perform pharmacokinetic studies of a nanosomal form of resveratrol. The techniques described here yield particles of submicron size, with resveratrol yields of 70-100% and resveratrol contents in lyophilized formulations reaching 15-20%. After oral administration of unmodified resveratrol to mice, only 19% of the dose was taken up into the blood, while use of nanosomal resveratrol formulations based on Eudragit RL and lecithin/chitosan increased bioavailability to 39% and 61% respectively. Increases in the peak plasma resveratrol concentration by factors of 4-5 were also seen in mice given nanoparticles. Thus, conversion of resveratrol to the nanosomal form leads to solubilization and resultant increases in absorption into the bloodstream.</abstract><cop>Boston</cop><pub>Boston : Springer US</pub><doi>10.1007/s11094-010-0401-1</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0091-150X
ispartof Pharmaceutical chemistry journal, 2010-06, Vol.44 (2), p.74-76
issn 0091-150X
1573-9031
language eng
recordid cdi_gale_infotracmisc_A359334795
source SpringerNature Journals
subjects Antioxidants
bioavailability
Heart attack
Medicine
Nanoparticles
Organic Chemistry
pharmacokinetics
Pharmacology/Toxicology
Pharmacy
Resveratrol
title Use of nanoparticles to increase the systemic bioavailability of trans-resveratrol
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T12%3A49%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Use%20of%20nanoparticles%20to%20increase%20the%20systemic%20bioavailability%20of%20trans-resveratrol&rft.jtitle=Pharmaceutical%20chemistry%20journal&rft.au=Oganesyan,%20E.%20A&rft.date=2010-06-01&rft.volume=44&rft.issue=2&rft.spage=74&rft.epage=76&rft.pages=74-76&rft.issn=0091-150X&rft.eissn=1573-9031&rft_id=info:doi/10.1007/s11094-010-0401-1&rft_dat=%3Cgale_cross%3EA359334795%3C/gale_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A359334795&rfr_iscdi=true